CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors

Glioblastoma (GBM) is the most aggressive cancer of the brain and has a high mortality rate due to the lack of effective treatment strategy. Clarification of molecular mechanisms of GBM’s characteristic invasive growth is urgently needed to improve the poor prognosis. Single-nuclear sequencing of pr...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHANG, BIN, ZHAO, JIANYI, WANG, YONGZHI, XU, HUA, GAO, BO, ZHANG, GUANGNING, HAN, BIN, SONG, GUOHONG, ZHANG, JUNCHEN, MENG, WEI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513942/
https://www.ncbi.nlm.nih.gov/pubmed/37744266
http://dx.doi.org/10.32604/or.2023.030425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513942/
https://www.ncbi.nlm.nih.gov/pubmed/37744266
http://dx.doi.org/10.32604/or.2023.030425

Ejemplares similares